Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeats

Journal of Cell Science

Volumn 124, Issue 10, 2011, Pages 1703-1714

  Querido, Emmanuelle ^a   Gallardo, Franck ^a   Beaudoin, Mélissa ^a   Ménard, Catherine ^a   Chartrand, Pascal ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

CUG repeat RNA; FRAP; Live cell microscopy; Mbnl1; MS2 GFP

Indexed keywords

MESSENGER RNA; PROTEIN MBNL1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; DMPK GENE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE; GENE CLUSTER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA INTERFERENCE;

ANIMALS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE EXPRESSION PROFILING; MICE; MYOTONIC DYSTROPHY; RNA, MESSENGER; STOCHASTIC PROCESSES; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION; TRINUCLEOTIDE REPEATS;

EID: 79956068320     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.073270     Document Type: Article

References (60)

1. Amack, J. D. and Mahadevan, M. S. (2001). The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum. Mol. Genet. 10, 1879-1887.
2. Bertrand, E., Chartrand, P., Schaefer, M., Shenoy, S. M., Singer, R. H. and Long, R. M. (1998). Localization of ASH1 mRNA particles in living yeast. Mol. Cell 2, 437-445.
3. Boireau, S., Maiuri, P., Basyuk, E., de la Mata, M., Knezevich, A., Pradet-Balade, B., Backer, V., Kornblihtt, A., Marcello, A. and Bertrand, E. (2007). The transcriptional cycle of HIV-1 in real-time and live cells. J. Cell Biol. 179, 291-304.
4. Botta, A., Rinaldi, F., Catalli, C., Vergani, L., Bonifazi, E., Romeo, V., Loro, E., Viola, A., Angelini, C. and Novelli, G. (2008). The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J. Med. Genet. 45, 639-646.
5. Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J. P., Hudson, T. et al. (1992). Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68, 799-808.
6. Buxton, J., Shelbourne, P., Davies, J., Jones, C., Van Tongeren, T., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B. et al. (1992). Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547-548.
7. Cardani, R., Mancinelli, E., Rotondo, G., Sansone, V. and Meola, G. (2006). Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur. J. Histochem. 50, 177-182.
8. Colby, D. W., Cassady, J. P., Lin, G. C., Ingram, V. M. and Wittrup, K. D. (2006). Stochastic kinetics of intracellular huntingtin aggregate formation. Nat. Chem. Biol. 2, 319-323.
9. Dansithong, W., Paul, S., Comai, L. and Reddy, S. (2005). MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem. 280, 5773-5780.
10. Daughters, R. S., Tuttle, D. L., Gao, W., Ikeda, Y., Moseley, M. L., Ebner, T. J., Swanson, M. S. and Ranum, L. P. W. (2009). RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. 5, e1000600.
11. Davis, B. M., McCurrach, M. E., Taneja, K. L., Singer, R. H. and Housman, D. E. (1997). Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94, 7388-7393.
12. Dhaenens, C. M., Schraen-Maschke, S., Tran, H., Vingtdeux, V., Ghanem, D., Leroy, O., Delplanque, J., Vanbrussel, E., Delacourte, A., Vermersch, P. et al. (2008). Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats. Exp. Neurol. 210, 467-478.
13. Fardaei, M., Larkin, K., Brook, J. D. and Hamshere, M. G. (2001). In vivo colocalisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 29, 2766-2771.
14. Fardaei, M., Rogers, M. T., Thorpe, H. M., Larkin, K., Hamshere, M. G., Harper, P. S. and Brook, J. D. (2002). Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 11, 805-814.
15. Fu, Y. H., Pizzuti, A., Fenwick, R. G., Jr, King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P. et al. (1992). An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256-1258.
16. Fusco, D., Accornero, N., Lavoie, B., Shenoy, S. M., Blanchard, J.-M., Singer, R. H. and Bertrand, E. (2003). Single mRNA molecules demonstrate probabilistic movement in living mammalian cells. Curr. Biol. 13, 161-167.
17. Hamshere, M. G., Newman, E. E., Alwazzan, M., Athwal, B. S. and Brook, J. D. (1997). Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc. Natl. Acad. Sci. USA 94, 7394-7399.
18. Harley, H. J., Brook, J. D., Rundle S. A., Crow, S., Reardon, W., Buckler, A. J., Harper, P. S., Housman, D. E. and Shaw, D. J. (1992). Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545-546.
19. Harper, P. S. (2001). Myotonic Dystrophy. London: WB Saunders Press.
20. Ho, T. H., Charlet-B, N., Poulos, M. G., Singh, G., Swanson, M. S. and Cooper, T. A. (2004). Muscleblind proteins regulate alternative splicing. EMBO J. 23, 3103-3112.
21. Ho, T. H., Savkur, R. S., Poulos, M. G., Mancini, M. A., Swanson, M. S. and Cooper, T. A. (2005). Colocalization of muscleblind with RNA foci is separable from misregulation of alternative splicing in myotonic dystrophy. J. Cell Sci. 118, 2923-2933.
22. Holt, I., Mittal, S., Furling, D., Butler-Browne, G. S., Brook, J. D. and Morris, G. E. (2007). Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cells 12, 1035-1048.
23. Holt, I., Jacquemin, V., Fardaei, M., Sewry, C. A., Butler-Browne, G. S., Furling, D., Brook, J. D. and Morris, G. E. (2009). Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. Am. J. Pathol. 174, 216-227.
24. Hortschansky, P., Schroeckh, V., Christopeit, T., Zandomeneghi, G. and Fändrich, M. (2005). The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 14, 1753-1759.
25. Iwahashi, C. K., Yasui, D. H., An, H. J., Greco, C. M., Tassone, F., Nannen, K., Babineau, B., Lebrilla, C. B., Hagerman, R. J. and Hagerman, P. J. (2006). Protein composition of the intranuclear inclusions of FXTAS. Brain 129, 256-271.
26. Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T. and Thornton, C. A. (2004). Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13, 3079-3088.
27. Kalsotra, A., Xiao, X., Ward, A. J., Castle, J. C., Johnson, J. M., Burge, C. B. and Cooper, T. A. (2008). A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. USA 105, 20333-20338.
28. Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W. and Swanson, M. S. (2003). A muscleblind knockout model for myotonic dystrophy. Science 302, 1978-1980.
29. Kim, D.-H., Langlois, M.-A., Lee, K.-B., Riggs, A. D., Puymirat, J. and Rossi, J. J. (2005). HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res. 33, 3866-3874.
30. Kino, Y., Washizu, C., Oma, Y., Onishi, H., Nezu, Y., Sasagawa, N., Nukina, N. and Ishiura, S. (2009). MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res. 37, 6477-6490.
31. Kuyumcu-Martinez, N. M. and Cooper, T. A. (2006). Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog. Mol. Subcell. Biol. 44, 133-159.
32. Li, L.-B., Yu, Z., Teng, X. and Bonini, N. M. (2008). RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453, 1107-1111.
33. Lim, F. and Peabody, D. S. (1994). Mutations that increase the affinity of a translational repressor for RNA. Nucleic Acids Res. 22, 3748-3752.
34. Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S. and Thornton, C. A. (2006). Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087-2097.
35. Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kress, W., Naylor, S. L., Day, J. W. and Ranum, L. P. W. (2001). Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293, 864-867.
36. Long, R. M., Elliott, D. J., Stutz, F., Rosbash, M. and Singer, R. H. (1995). Spatial consequences of defective processing of specific yeast mRNAs revealed by fluorescent in situ hybridization. RNA 1, 1071-1078.
37. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., Jansen, G., Neville, C., Narang, M., Barcelo, J., O'Hoy, K. et al. (1992). Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255, 1253-1255.
38. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M. and Thornton, C. A. (2000). Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769-1772.
39. Mankodi, A., Urbinati, C. R., Yuan, Q.-P., Moxley, R. T., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M. S. and Thornton, C. A. (2001). Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10, 2165-2170.
40. Mankodi, A., Teng-Umnuay, P., Krym, M., Henderson, D., Swanson, M. and Thornton, C. A. (2003). Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann. Neurol. 54, 760-768.
41. Mankodi, A., Lin, X., Blaxall, B. C., Swanson, M. S. and Thornton, C. A. (2005). Nuclear RNA foci in the heart in myotonic dystrophy. Circ. Res. 97, 1152-1155.
42. Miller, J. W., Urbinati, C. R., Teng-Umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A. and Swanson, M. S. (2000). Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439-4448.
43. Mollet, S., Cougot, N., Wilczynska, A., Dautry, F., Kress, M., Bertrand, E. and Weil, D. (2008). Translationally repressed mRNA transiently cycles through stress granules during stress. Mol. Biol. Cell 19, 4469-4479.
44. Morgenstern, J. P. and Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
45. Mulders, S. A. M., van den Broek, W. J. A. A., Wheeler, T. M., Croes, H. J. E., van Kuik-Romeijn, P., de Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A. et al. (2009). Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl. Acad. Sci. USA 106, 13915-13920.
46. Nykamp, K. R. and Swanson, M. S. (2004). Toxic RNA in the nucleus: unstable microsatellite expression in neuromuscular disease. Prog. Mol. Subcell. Biol. 35, 57-77.
47. Osborne, R. J., Lin, X., Welle, S., Sobczak, K., O'Rourke, J. R., Swanson, M. S. and Thornton, C. A. (2009). Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum. Mol. Genet. 18, 1471-1481.
48. Paul, S., Dansithong, W., Kim, D., Rossi, J., Webster, N. J., Comai, L., Reddy, S. (2006). Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J. 25, 4271-4283.
49. Querido, E. and Chartrand, P. (2008). Using fluorescent proteins to study mRNA trafficking in living cells. In Methods in Cell Biology, (ed. Kevin F. Sullivan), Vol. 85, pp. 273-292. Elsevier Academic Press Inc, San Diego, CA, USA.
50. Ranum, L. P. W. and Cooper, T. A. (2006). RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 29, 259-277.
51. Ranum, L. P. W. and Day, J. W. (2004). Myotonic dystrophy: RNA pathogenesis comes into focus. Am. J. Hum. Genet. 74, 793-804.
52. Rudnicki, D. D., Holmes, S. E., Lin, M. W., Thornton, C. A., Ross, C. A. and Margolis, R. L. (2007). Huntington's disease-like 2 is associated with CUG repeat-containing RNA foci. Ann. Neurol. 61, 272-282.
53. Shaner, N. C., Steinbach, P. A. and Tsien, R. Y. (2005). A guide to choosing fluorescent proteins. Nat. Methods 2, 905-909.
54. Shav-Tal, Y., Darzacq, X., Shenoy, S. M., Fusco, D., Janicki, S. M., Spector, D. L. and Singer, R. H. (2004). Dynamics of single mRNPs in nuclei of living cells. Science 304, 1797-1800.
55. Smith, K. P., Byron, M., Johnson, C., Xing, Y. and Lawrence, J. B. (2007). Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains. J. Cell Biol. 178, 951-964.
56. Taneja, K. L., McCurrach, M., Schalling, M., Housman, D. and Singer, R. H. (1995). Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128, 995-1002.
57. Tassone, F., Iwahashi, C. and Hagerman, P. J. (2004). FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol. 1, 103-105.
58. Wheeler, T. M., Krym, M. C. and Thornton, C. A. (2007). Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1. Neuromuscular disorders: NMD 17, 242-247.
59. Wheeler, T. M., Sobczak, K., Lueck, J. D., Osborne, R. J., Lin, X., Dirksen, R. T. and Thornton, C. A. (2009). Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325, 336-339.
60. Yuan, Y., Compton, S. A., Sobczak, K., Stenberg, M. G., Thornton, C. A., Griffith, J. D. and Swanson, M. S. (2007). Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 35, 5474-5486.